Welcome to our dedicated page for Albemarle news (Ticker: ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle stock.
Albemarle Corporation reports news on its role as a global producer of lithium and bromine used in mobility, energy, connectivity and health applications. Company updates commonly cover Energy Storage and Specialties performance, lithium market pricing and volumes, bromine-based solutions, operational productivity, and cash generation.
Recurring developments also include quarterly earnings releases, common stock dividends, debt tender offers and note redemptions, board and committee appointments, and portfolio actions. Recent corporate updates include the completed sale of a controlling stake in Ketjen's refining catalyst solutions business, Albemarle's retained minority interest in Ketjen, and the integration of Performance Catalyst Solutions into Albemarle's product portfolio.
Albemarle (NYSE: ALB) reported Q1 2026 results with net sales of $1.43 billion (up 33%) and adjusted EBITDA of $664 million (up 148%). Energy Storage sales rose ~70% and adjusted EBITDA increased ~196%. The company generated $248 million free cash flow, closed asset sales for $648 million, and paid down $1.3 billion of debt.
Albemarle maintained FY 2026 capex guidance of $550–$600 million, raised Specialties outlook, and expects interest expense of $120–$140 million after debt reductions; scenarios for FY 2026 results vary by lithium price environment.
Albemarle (NYSE: ALB) declared a quarterly common stock dividend of $0.405 per share, equal to an annualized rate of $1.62. The dividend is payable on July 1, 2026 to shareholders of record at the close of business on June 12, 2026.
Contact information for investor and media inquiries is provided.
Albemarle (NYSE: ALB) will release first quarter 2026 earnings after the NYSE close on May 6, 2026 and host a conference call on May 7, 2026 at 8:00 a.m. EDT. Access is available via webcast or direct dial; a replay will be posted on the investor website.
Participant dial-in numbers and a webcast link are provided for investors and media; investor and media contact details are listed.
Albemarle (NYSE: ALB) priced cash tender offers to purchase up to $650 million aggregate principal amount of senior notes using a waterfall acceptance priority. The company expects to accept $254.32M of 5.650% 2052 notes, $149.034M of 5.450% 2044 notes, $62.372M of 3.450% 2029 notes and $184.274M of 5.050% 2032 notes on an early settlement basis.
The Total Consideration includes a $50 per $1,000 early tender premium and accrued interest to, but excluding, March 18, 2026. Because early tenders exceeded the $650 million target, no final settlement date will occur and post-early tenders will not be accepted.
Albemarle (NYSE: ALB) announced early tender results and increased the cash Offer Cap from $500 million to $650 million for previously announced tender offers for certain senior notes. The company reported aggregate principal tendered by series, an Early Tender Premium of $50 per $1,000, and set the Early Settlement Date for March 18, 2026.
The Company will determine Total Consideration at 10:00 a.m. ET on March 16, 2026 and will accept notes using a waterfall by Acceptance Priority Level.
Albemarle (NYSE: ALB) appointed Michelle T. Collins and Mark R. Widmar to its Board of Directors, effective February 26, 2026. Collins will join the Audit & Finance and Governance & Public Policy committees; Widmar will join Executive Compensation & Talent Development and Safety, Sustainability, Operations & Capital.
Collins brings 40+ years in audit and advisory, including senior leadership at Deloitte; Widmar brings CEO and CFO experience at First Solar and other public companies. The appointments reflect board succession planning and governance priorities.
Albemarle (NYSE: ALB) launched cash tender offers for four series of senior notes with an Offer Cap of $500 million and will fully redeem its $650 million 4.650% senior notes due 2027 on March 12, 2026.
Early Tender Time is March 13, 2026; Offers expire March 30, 2026; Early Settlement expected March 18, 2026; Final Settlement April 1, 2026. Each accepted tender pays a $50 per $1,000 early tender premium.
Albemarle (NYSE: ALB) completed sale of a controlling stake in Ketjen's refining catalyst solutions business to KPS Capital Partners on March 2, 2026, while retaining a minority stake and full ownership of Ketjen's Performance Catalyst Solutions business, which Albemarle integrated into its portfolio. Combined with a January 2026 sale of a 50% Eurecat interest, Albemarle received $670 million in pre-tax proceeds to be used for debt reduction and general corporate purposes.
Albemarle (NYSE: ALB) declared a quarterly common stock dividend of $0.405 per share, equal to an annualized rate of $1.62. The dividend is payable April 1, 2026 to shareholders of record at the close of business on March 13, 2026.
The announcement reiterates standard forward-looking disclosures and references factors that could affect future dividends and results.
Albemarle (NYSE: ALB) will idle Train 1 at its Kemerton lithium hydroxide plant in Western Australia and place it into care and maintenance effective immediately. This follows 2024 actions to idle Train 2 and to cease expansion plans for Trains 3 and 4.
The plant processes spodumene from Greenbushes. Albemarle said the decision improves financial flexibility, is expected to be accretive to adjusted EBITDA beginning in Q2 2026, and will not affect projected 2026 volumes. Mining interests in Australia remain unchanged.